Ascendis Pharma A (ASND) Gross Margin (QoQ) (2021 - 2026)
Ascendis Pharma A (ASND) Gross Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Ascendis Pharma A | 15.46 Bn | 14.79 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,913.00 |
| Dec 31, 2025 | -3,577.00 |
| Sep 30, 2025 | 943.00 |
| Jun 30, 2025 | -255.00 |
| Mar 31, 2025 | 3,107.00 |
| Dec 31, 2024 | -2,905.00 |
| Sep 30, 2024 | 1,248.00 |
| Jun 30, 2024 | -2,396.00 |
| Mar 31, 2024 | 5,304.00 |
| Dec 31, 2023 | -4,556.00 |
| Sep 30, 2023 | 1,190.00 |
| Jun 30, 2023 | -1,352.00 |
| Mar 31, 2023 | 857.00 |
| Dec 31, 2022 | -1,125.00 |
| Sep 30, 2022 | 656.00 |
| Jun 30, 2022 | 4,456.00 |
| Mar 31, 2022 | 3,622.00 |
| Dec 31, 2021 | -9,840.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |